Crystallographic study, biological assessment and POM/Docking studies of pyrazoles-sulfonamide hybrids (PSH): Identification of a combined Antibacterial/Antiviral pharmacophore sites leading to in-silico screening the anti-Covid-19 activity

•New pyrazole-sulfonamides hybrids were designed and synthesized.•The structure of the compound 4b was confirmed by single crystal X-ray diffraction.•The in vitro antimicrobial and antioxidant activities of the targeted compounds were carried out.•Some compounds represent interesting dual acting ant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of molecular structure 2022-11, Vol.1267, p.133605-133605, Article 133605
Hauptverfasser: Chalkha, Mohammed, Nakkabi, Asmae, Hadda, Taibi Ben, Berredjem, Malika, Moussaoui, Abdelfattah El, Bakhouch, Mohamed, Saadi, Mohamed, Ammari, Lahcen El, Almalki, Faisal A., Laaroussi, Hamid, Jevtovic, Violeta, Yazidi, Mohamed El
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 133605
container_issue
container_start_page 133605
container_title Journal of molecular structure
container_volume 1267
creator Chalkha, Mohammed
Nakkabi, Asmae
Hadda, Taibi Ben
Berredjem, Malika
Moussaoui, Abdelfattah El
Bakhouch, Mohamed
Saadi, Mohamed
Ammari, Lahcen El
Almalki, Faisal A.
Laaroussi, Hamid
Jevtovic, Violeta
Yazidi, Mohamed El
description •New pyrazole-sulfonamides hybrids were designed and synthesized.•The structure of the compound 4b was confirmed by single crystal X-ray diffraction.•The in vitro antimicrobial and antioxidant activities of the targeted compounds were carried out.•Some compounds represent interesting dual acting antimicrobial and antioxidant activities.•The antimicrobial activity was supported by molecular docking and POM studies.•A good correlation between the experimental results and POM/Docking studies was observed.•Potential antiviral pharmacophore site (Oδ−, Oδ−) was identified in the POM investigations.•Virtual screening by molecular docking was performed to test binding affinity of the compounds PSH with the essential protein of SARS-CoV-2. The discovery and development of new potent antimicrobial and antioxidant agents is an essential lever to protect living beings against pathogenic microorganisms and free radicals. In this regard, new functionalized pyrazoles have been synthesized using a simple and accessible approach. The synthesized aminobenzoylpyrazoles 3a-h and pyrazole-sulfonamides 4a-g were obtained in good yields and were evaluated in vitro for their antimicrobial and antioxidant activities. The structures of the synthesized compounds were determined using IR, NMR, and mass spectrometry. The structure of the compound 4b was further confirmed by single crystal X-ray diffraction. The results of the in vitro screening show that the synthesized pyrazoles 3 and 4 exhibit a promising antimicrobial and antioxidant activities. Among the tested compounds, pyrazoles 3a, 3f, 4e, 4f, and 4g have exhibited remarkable antimicrobial activity against some microorganisms. In addition, compounds 3a, 3c, 3e, 4a, 4d, 4f, and 4g have shown a significant antioxidant activity in comparison with the standard butylhydroxytoluene (BHT). Hence, compounds 3a, 4f, and 4g represent interesting dual acting antimicrobial and antioxidant agents. In fact, pyrazole derivatives bearing sulfonamide moiety (4a-g) have displayed an important antimicrobial activity compared to pyrazoles 3a-h, this finding could be attributed to the synergistic effect of the pyrazole and sulfonamide pharmacophores. Furthermore, Molecular docking results revealed a good interaction of the synthesized compounds with the target proteins and provided important information about their interaction modes with the target enzyme. The results of the POM bioinformatics investigations (Petra, Osiris, Molinspiration) show th
doi_str_mv 10.1016/j.molstruc.2022.133605
format Article
fullrecord <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9237569</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022286022012613</els_id><sourcerecordid>S0022286022012613</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-ee02d025a4e5e432029374858c3f88dbeab517db3483e33f65dbebb339d0a2bd3</originalsourceid><addsrcrecordid>eNqFUstuFDEQHCEQCYFfiHwEidn1Y17LASVaHokUlEjA2fKjZ6eXmfHI9q40fDWfgDdLIjhxstzVVdVtV5adM7pglFXL7WJwfYh-Zxaccr5gQlS0fJKdsqbmeUNZ8TQ7pQnJeVPRk-xFCFtKKUvk59mJKOuGC8ZPs19rP4eo-t5tvJo6NCTEnZ3fEo0u1dConqgQIIQBxkjUaMnd7ZflB2d-4Li5b0YIxLVkmr366XoIedj1rRvVgBZIN2uPNpDXd1-v3rwj1zapYJtkI7rxQFPEuEHjCJZcJkgrE8Gj6peH2x598p865Qdl3NQ5DyRgTIY9KHsYIDqCYx6wR-NIMB5gvC93kGaNmK_dHm3OViTpJrk4v8yetaoP8OrPeZZ9__Tx2_oqv7n9fL2-vMlNUbOYA1BuKS9VASUUIr3xStRFUzZGtE1jNShdstpqUTQChGirMtW0FmJlqeLairPs_VF32ukBrEl7p13k5HFQfpZOofwXGbGTG7eXKy7qslolgeooYLwLwUP7yGVUHjIgt_IhA_KQAXnMQCKe_-38SHv49NRwcWyAtP8ewctgEEYDFj2YKK3D_3n8Bu_sz3A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Crystallographic study, biological assessment and POM/Docking studies of pyrazoles-sulfonamide hybrids (PSH): Identification of a combined Antibacterial/Antiviral pharmacophore sites leading to in-silico screening the anti-Covid-19 activity</title><source>Elsevier ScienceDirect Journals</source><creator>Chalkha, Mohammed ; Nakkabi, Asmae ; Hadda, Taibi Ben ; Berredjem, Malika ; Moussaoui, Abdelfattah El ; Bakhouch, Mohamed ; Saadi, Mohamed ; Ammari, Lahcen El ; Almalki, Faisal A. ; Laaroussi, Hamid ; Jevtovic, Violeta ; Yazidi, Mohamed El</creator><creatorcontrib>Chalkha, Mohammed ; Nakkabi, Asmae ; Hadda, Taibi Ben ; Berredjem, Malika ; Moussaoui, Abdelfattah El ; Bakhouch, Mohamed ; Saadi, Mohamed ; Ammari, Lahcen El ; Almalki, Faisal A. ; Laaroussi, Hamid ; Jevtovic, Violeta ; Yazidi, Mohamed El</creatorcontrib><description>•New pyrazole-sulfonamides hybrids were designed and synthesized.•The structure of the compound 4b was confirmed by single crystal X-ray diffraction.•The in vitro antimicrobial and antioxidant activities of the targeted compounds were carried out.•Some compounds represent interesting dual acting antimicrobial and antioxidant activities.•The antimicrobial activity was supported by molecular docking and POM studies.•A good correlation between the experimental results and POM/Docking studies was observed.•Potential antiviral pharmacophore site (Oδ−, Oδ−) was identified in the POM investigations.•Virtual screening by molecular docking was performed to test binding affinity of the compounds PSH with the essential protein of SARS-CoV-2. The discovery and development of new potent antimicrobial and antioxidant agents is an essential lever to protect living beings against pathogenic microorganisms and free radicals. In this regard, new functionalized pyrazoles have been synthesized using a simple and accessible approach. The synthesized aminobenzoylpyrazoles 3a-h and pyrazole-sulfonamides 4a-g were obtained in good yields and were evaluated in vitro for their antimicrobial and antioxidant activities. The structures of the synthesized compounds were determined using IR, NMR, and mass spectrometry. The structure of the compound 4b was further confirmed by single crystal X-ray diffraction. The results of the in vitro screening show that the synthesized pyrazoles 3 and 4 exhibit a promising antimicrobial and antioxidant activities. Among the tested compounds, pyrazoles 3a, 3f, 4e, 4f, and 4g have exhibited remarkable antimicrobial activity against some microorganisms. In addition, compounds 3a, 3c, 3e, 4a, 4d, 4f, and 4g have shown a significant antioxidant activity in comparison with the standard butylhydroxytoluene (BHT). Hence, compounds 3a, 4f, and 4g represent interesting dual acting antimicrobial and antioxidant agents. In fact, pyrazole derivatives bearing sulfonamide moiety (4a-g) have displayed an important antimicrobial activity compared to pyrazoles 3a-h, this finding could be attributed to the synergistic effect of the pyrazole and sulfonamide pharmacophores. Furthermore, Molecular docking results revealed a good interaction of the synthesized compounds with the target proteins and provided important information about their interaction modes with the target enzyme. The results of the POM bioinformatics investigations (Petra, Osiris, Molinspiration) show that the studied heterocycles present a very good non toxicity profile, an excellent bioavailability, and pharmacokinetics. Finally, an antiviral pharmacophore (O δ−, O δ−) was evaluated in the POM investigations and deserves all our attention to be tested against Covid-19 and its Omicron and Delta mutants. [Display omitted]</description><identifier>ISSN: 0022-2860</identifier><identifier>EISSN: 1872-8014</identifier><identifier>DOI: 10.1016/j.molstruc.2022.133605</identifier><identifier>PMID: 35782312</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Antimicrobial/Antioxidant bioactivity ; Docking study ; Identification of the pharmacophore sites ; Petra/Osiris/Molinspiration (POM) analyses ; Pyrazole Linked Sulfonamide Conjugates</subject><ispartof>Journal of molecular structure, 2022-11, Vol.1267, p.133605-133605, Article 133605</ispartof><rights>2022 Elsevier B.V.</rights><rights>2022 Elsevier B.V. All rights reserved.</rights><rights>2022 Elsevier B.V. All rights reserved. 2022 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-ee02d025a4e5e432029374858c3f88dbeab517db3483e33f65dbebb339d0a2bd3</citedby><cites>FETCH-LOGICAL-c471t-ee02d025a4e5e432029374858c3f88dbeab517db3483e33f65dbebb339d0a2bd3</cites><orcidid>0000-0003-2655-0230 ; 0000-0003-0732-6524 ; 0000-0002-8502-6239 ; 0000-0002-9400-2183 ; 0000-0002-5633-6203</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022286022012613$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35782312$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chalkha, Mohammed</creatorcontrib><creatorcontrib>Nakkabi, Asmae</creatorcontrib><creatorcontrib>Hadda, Taibi Ben</creatorcontrib><creatorcontrib>Berredjem, Malika</creatorcontrib><creatorcontrib>Moussaoui, Abdelfattah El</creatorcontrib><creatorcontrib>Bakhouch, Mohamed</creatorcontrib><creatorcontrib>Saadi, Mohamed</creatorcontrib><creatorcontrib>Ammari, Lahcen El</creatorcontrib><creatorcontrib>Almalki, Faisal A.</creatorcontrib><creatorcontrib>Laaroussi, Hamid</creatorcontrib><creatorcontrib>Jevtovic, Violeta</creatorcontrib><creatorcontrib>Yazidi, Mohamed El</creatorcontrib><title>Crystallographic study, biological assessment and POM/Docking studies of pyrazoles-sulfonamide hybrids (PSH): Identification of a combined Antibacterial/Antiviral pharmacophore sites leading to in-silico screening the anti-Covid-19 activity</title><title>Journal of molecular structure</title><addtitle>J Mol Struct</addtitle><description>•New pyrazole-sulfonamides hybrids were designed and synthesized.•The structure of the compound 4b was confirmed by single crystal X-ray diffraction.•The in vitro antimicrobial and antioxidant activities of the targeted compounds were carried out.•Some compounds represent interesting dual acting antimicrobial and antioxidant activities.•The antimicrobial activity was supported by molecular docking and POM studies.•A good correlation between the experimental results and POM/Docking studies was observed.•Potential antiviral pharmacophore site (Oδ−, Oδ−) was identified in the POM investigations.•Virtual screening by molecular docking was performed to test binding affinity of the compounds PSH with the essential protein of SARS-CoV-2. The discovery and development of new potent antimicrobial and antioxidant agents is an essential lever to protect living beings against pathogenic microorganisms and free radicals. In this regard, new functionalized pyrazoles have been synthesized using a simple and accessible approach. The synthesized aminobenzoylpyrazoles 3a-h and pyrazole-sulfonamides 4a-g were obtained in good yields and were evaluated in vitro for their antimicrobial and antioxidant activities. The structures of the synthesized compounds were determined using IR, NMR, and mass spectrometry. The structure of the compound 4b was further confirmed by single crystal X-ray diffraction. The results of the in vitro screening show that the synthesized pyrazoles 3 and 4 exhibit a promising antimicrobial and antioxidant activities. Among the tested compounds, pyrazoles 3a, 3f, 4e, 4f, and 4g have exhibited remarkable antimicrobial activity against some microorganisms. In addition, compounds 3a, 3c, 3e, 4a, 4d, 4f, and 4g have shown a significant antioxidant activity in comparison with the standard butylhydroxytoluene (BHT). Hence, compounds 3a, 4f, and 4g represent interesting dual acting antimicrobial and antioxidant agents. In fact, pyrazole derivatives bearing sulfonamide moiety (4a-g) have displayed an important antimicrobial activity compared to pyrazoles 3a-h, this finding could be attributed to the synergistic effect of the pyrazole and sulfonamide pharmacophores. Furthermore, Molecular docking results revealed a good interaction of the synthesized compounds with the target proteins and provided important information about their interaction modes with the target enzyme. The results of the POM bioinformatics investigations (Petra, Osiris, Molinspiration) show that the studied heterocycles present a very good non toxicity profile, an excellent bioavailability, and pharmacokinetics. Finally, an antiviral pharmacophore (O δ−, O δ−) was evaluated in the POM investigations and deserves all our attention to be tested against Covid-19 and its Omicron and Delta mutants. [Display omitted]</description><subject>Antimicrobial/Antioxidant bioactivity</subject><subject>Docking study</subject><subject>Identification of the pharmacophore sites</subject><subject>Petra/Osiris/Molinspiration (POM) analyses</subject><subject>Pyrazole Linked Sulfonamide Conjugates</subject><issn>0022-2860</issn><issn>1872-8014</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFUstuFDEQHCEQCYFfiHwEidn1Y17LASVaHokUlEjA2fKjZ6eXmfHI9q40fDWfgDdLIjhxstzVVdVtV5adM7pglFXL7WJwfYh-Zxaccr5gQlS0fJKdsqbmeUNZ8TQ7pQnJeVPRk-xFCFtKKUvk59mJKOuGC8ZPs19rP4eo-t5tvJo6NCTEnZ3fEo0u1dConqgQIIQBxkjUaMnd7ZflB2d-4Li5b0YIxLVkmr366XoIedj1rRvVgBZIN2uPNpDXd1-v3rwj1zapYJtkI7rxQFPEuEHjCJZcJkgrE8Gj6peH2x598p865Qdl3NQ5DyRgTIY9KHsYIDqCYx6wR-NIMB5gvC93kGaNmK_dHm3OViTpJrk4v8yetaoP8OrPeZZ9__Tx2_oqv7n9fL2-vMlNUbOYA1BuKS9VASUUIr3xStRFUzZGtE1jNShdstpqUTQChGirMtW0FmJlqeLairPs_VF32ukBrEl7p13k5HFQfpZOofwXGbGTG7eXKy7qslolgeooYLwLwUP7yGVUHjIgt_IhA_KQAXnMQCKe_-38SHv49NRwcWyAtP8ewctgEEYDFj2YKK3D_3n8Bu_sz3A</recordid><startdate>20221105</startdate><enddate>20221105</enddate><creator>Chalkha, Mohammed</creator><creator>Nakkabi, Asmae</creator><creator>Hadda, Taibi Ben</creator><creator>Berredjem, Malika</creator><creator>Moussaoui, Abdelfattah El</creator><creator>Bakhouch, Mohamed</creator><creator>Saadi, Mohamed</creator><creator>Ammari, Lahcen El</creator><creator>Almalki, Faisal A.</creator><creator>Laaroussi, Hamid</creator><creator>Jevtovic, Violeta</creator><creator>Yazidi, Mohamed El</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2655-0230</orcidid><orcidid>https://orcid.org/0000-0003-0732-6524</orcidid><orcidid>https://orcid.org/0000-0002-8502-6239</orcidid><orcidid>https://orcid.org/0000-0002-9400-2183</orcidid><orcidid>https://orcid.org/0000-0002-5633-6203</orcidid></search><sort><creationdate>20221105</creationdate><title>Crystallographic study, biological assessment and POM/Docking studies of pyrazoles-sulfonamide hybrids (PSH): Identification of a combined Antibacterial/Antiviral pharmacophore sites leading to in-silico screening the anti-Covid-19 activity</title><author>Chalkha, Mohammed ; Nakkabi, Asmae ; Hadda, Taibi Ben ; Berredjem, Malika ; Moussaoui, Abdelfattah El ; Bakhouch, Mohamed ; Saadi, Mohamed ; Ammari, Lahcen El ; Almalki, Faisal A. ; Laaroussi, Hamid ; Jevtovic, Violeta ; Yazidi, Mohamed El</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-ee02d025a4e5e432029374858c3f88dbeab517db3483e33f65dbebb339d0a2bd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antimicrobial/Antioxidant bioactivity</topic><topic>Docking study</topic><topic>Identification of the pharmacophore sites</topic><topic>Petra/Osiris/Molinspiration (POM) analyses</topic><topic>Pyrazole Linked Sulfonamide Conjugates</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chalkha, Mohammed</creatorcontrib><creatorcontrib>Nakkabi, Asmae</creatorcontrib><creatorcontrib>Hadda, Taibi Ben</creatorcontrib><creatorcontrib>Berredjem, Malika</creatorcontrib><creatorcontrib>Moussaoui, Abdelfattah El</creatorcontrib><creatorcontrib>Bakhouch, Mohamed</creatorcontrib><creatorcontrib>Saadi, Mohamed</creatorcontrib><creatorcontrib>Ammari, Lahcen El</creatorcontrib><creatorcontrib>Almalki, Faisal A.</creatorcontrib><creatorcontrib>Laaroussi, Hamid</creatorcontrib><creatorcontrib>Jevtovic, Violeta</creatorcontrib><creatorcontrib>Yazidi, Mohamed El</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of molecular structure</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chalkha, Mohammed</au><au>Nakkabi, Asmae</au><au>Hadda, Taibi Ben</au><au>Berredjem, Malika</au><au>Moussaoui, Abdelfattah El</au><au>Bakhouch, Mohamed</au><au>Saadi, Mohamed</au><au>Ammari, Lahcen El</au><au>Almalki, Faisal A.</au><au>Laaroussi, Hamid</au><au>Jevtovic, Violeta</au><au>Yazidi, Mohamed El</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Crystallographic study, biological assessment and POM/Docking studies of pyrazoles-sulfonamide hybrids (PSH): Identification of a combined Antibacterial/Antiviral pharmacophore sites leading to in-silico screening the anti-Covid-19 activity</atitle><jtitle>Journal of molecular structure</jtitle><addtitle>J Mol Struct</addtitle><date>2022-11-05</date><risdate>2022</risdate><volume>1267</volume><spage>133605</spage><epage>133605</epage><pages>133605-133605</pages><artnum>133605</artnum><issn>0022-2860</issn><eissn>1872-8014</eissn><abstract>•New pyrazole-sulfonamides hybrids were designed and synthesized.•The structure of the compound 4b was confirmed by single crystal X-ray diffraction.•The in vitro antimicrobial and antioxidant activities of the targeted compounds were carried out.•Some compounds represent interesting dual acting antimicrobial and antioxidant activities.•The antimicrobial activity was supported by molecular docking and POM studies.•A good correlation between the experimental results and POM/Docking studies was observed.•Potential antiviral pharmacophore site (Oδ−, Oδ−) was identified in the POM investigations.•Virtual screening by molecular docking was performed to test binding affinity of the compounds PSH with the essential protein of SARS-CoV-2. The discovery and development of new potent antimicrobial and antioxidant agents is an essential lever to protect living beings against pathogenic microorganisms and free radicals. In this regard, new functionalized pyrazoles have been synthesized using a simple and accessible approach. The synthesized aminobenzoylpyrazoles 3a-h and pyrazole-sulfonamides 4a-g were obtained in good yields and were evaluated in vitro for their antimicrobial and antioxidant activities. The structures of the synthesized compounds were determined using IR, NMR, and mass spectrometry. The structure of the compound 4b was further confirmed by single crystal X-ray diffraction. The results of the in vitro screening show that the synthesized pyrazoles 3 and 4 exhibit a promising antimicrobial and antioxidant activities. Among the tested compounds, pyrazoles 3a, 3f, 4e, 4f, and 4g have exhibited remarkable antimicrobial activity against some microorganisms. In addition, compounds 3a, 3c, 3e, 4a, 4d, 4f, and 4g have shown a significant antioxidant activity in comparison with the standard butylhydroxytoluene (BHT). Hence, compounds 3a, 4f, and 4g represent interesting dual acting antimicrobial and antioxidant agents. In fact, pyrazole derivatives bearing sulfonamide moiety (4a-g) have displayed an important antimicrobial activity compared to pyrazoles 3a-h, this finding could be attributed to the synergistic effect of the pyrazole and sulfonamide pharmacophores. Furthermore, Molecular docking results revealed a good interaction of the synthesized compounds with the target proteins and provided important information about their interaction modes with the target enzyme. The results of the POM bioinformatics investigations (Petra, Osiris, Molinspiration) show that the studied heterocycles present a very good non toxicity profile, an excellent bioavailability, and pharmacokinetics. Finally, an antiviral pharmacophore (O δ−, O δ−) was evaluated in the POM investigations and deserves all our attention to be tested against Covid-19 and its Omicron and Delta mutants. [Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>35782312</pmid><doi>10.1016/j.molstruc.2022.133605</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-2655-0230</orcidid><orcidid>https://orcid.org/0000-0003-0732-6524</orcidid><orcidid>https://orcid.org/0000-0002-8502-6239</orcidid><orcidid>https://orcid.org/0000-0002-9400-2183</orcidid><orcidid>https://orcid.org/0000-0002-5633-6203</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-2860
ispartof Journal of molecular structure, 2022-11, Vol.1267, p.133605-133605, Article 133605
issn 0022-2860
1872-8014
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9237569
source Elsevier ScienceDirect Journals
subjects Antimicrobial/Antioxidant bioactivity
Docking study
Identification of the pharmacophore sites
Petra/Osiris/Molinspiration (POM) analyses
Pyrazole Linked Sulfonamide Conjugates
title Crystallographic study, biological assessment and POM/Docking studies of pyrazoles-sulfonamide hybrids (PSH): Identification of a combined Antibacterial/Antiviral pharmacophore sites leading to in-silico screening the anti-Covid-19 activity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T19%3A07%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Crystallographic%20study,%20biological%20assessment%20and%20POM/Docking%20studies%20of%20pyrazoles-sulfonamide%20hybrids%20(PSH):%20Identification%20of%20a%20combined%20Antibacterial/Antiviral%20pharmacophore%20sites%20leading%20to%20in-silico%20screening%20the%20anti-Covid-19%20activity&rft.jtitle=Journal%20of%20molecular%20structure&rft.au=Chalkha,%20Mohammed&rft.date=2022-11-05&rft.volume=1267&rft.spage=133605&rft.epage=133605&rft.pages=133605-133605&rft.artnum=133605&rft.issn=0022-2860&rft.eissn=1872-8014&rft_id=info:doi/10.1016/j.molstruc.2022.133605&rft_dat=%3Celsevier_pubme%3ES0022286022012613%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/35782312&rft_els_id=S0022286022012613&rfr_iscdi=true